A comprehensive view of biontech se. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA approves Pfizer COVID-19 booster shots for healthy 5-to-11 year-old children, as CDC decides whether to approved booster; about 30% of eligible kids in 5-to-11 age group have received two doses of Pfizer vaccination

Atrium Health Levine Children’s Hospital in Charlotte, North Carolina, starts Pfizer-BioNTech COVID-19 vaccine study in healthy children ages six months old to under five years of age; over 350 million doses of the vaccine have been administered in US

Rutgers University enrolling up to 150 children with symptomatic cases of COVID-19 for Phase 2/3 trial of Pfizer-BioNTech’s oral Paxlovid nirmatrelvir, ritonavir antiviral treatment; the university is one of multiple worldwide sites in study

COVID-19 vaccine makers prepare for smaller booster vaccine market as demand for first shots falls; global booster shot market, including people over 50, adults with health risk factors or who work in high-risk occupations, estimated at 1.7 billion people

Pfizer, BioNTech announced data from Phase2/3 clinical trial of their COVID-19 vaccine booster in children aged 5-11 shows 36-fold increase in Omicron neutralizing titers; companies to submit request for FDA emergency use authorization of booster dose

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count